TP53 mutations mostly occur in its DNA-binding domain coding region, interfering with p53’s ability to bind to DNA and transactivate downstream genes, thus promoting different cancers, including cervical cancer (Kato et al., 2003; Banister et al., 2017; He et al., 2019a). This evidence concerns the gene TP53 and cancer.